Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis [0.03%]
印度尼西亚较高剂量伯氨喹根治间日疟的疗效：系统评价和个体患者数据 Meta 分析
Ihsan Fadilah,James A Watson,Ayodhia P Pasaribu et al.
Ihsan Fadilah et al.
Background: Plasmodium vivax malaria has diverse transmission and relapse patterns in Indonesia. The optimal dose of primaquine to prevent relapses across the country is unknown. We evaluated the anti-relapse efficacy, ga...
HIV cascade, key indicators, and other epidemiological metrics in Australia (2004-2023): a retrospective analysis [0.03%]
澳大利亚艾滋病治疗依从链、关键指标及其他流行病学指标的回顾性分析（2004-2023年）
Richard T Gray,Hamish McManus,Jonathan M King et al.
Richard T Gray et al.
Background: We aimed to describe Australia's overall progress towards ending AIDS as a public health threat between 2004 and 2023 using a retrospective analysis of the HIV cascade, key indicators, and other epidemiologica...
High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of Plasmodium vivax malaria: a safety study in Papua New Guinea and Indonesia [0.03%]
通过新型检测试剂盒检测后使用大剂量短疗程普鲁斯卡宁治疗间日疟根治的安全性研究：巴布亚新几内亚和印度尼西亚研究报告
Liony Fransisca,Maria Ome-Kaius,Moses Laman et al.
Liony Fransisca et al.
Background: High total dose primaquine (PQ 7 mg/kg) over 7 days can improve treatment adherence and reduce Plasmodium vivax malaria recurrences. We evaluated the safety of pre-treatment glucose-6-phosphate dehydrogenase (...
Can combined biomarker testing shape the future of primary care antibiotic prescribing? [0.03%]
联合生物标志物检测能否塑造未来基层医疗抗生素处方的未来？
Carl Llor,Niels Kristian Kjær
Carl Llor
Systematic review of cardiovascular care delivery across health systems in the Asia-Pacific: a regional roadmap for strengthening cardiovascular care [0.03%]
亚太地区医疗体系心血管护理的系统评价：加强心血管护理的区域路线图
Nicholas Ws Chew,Gwyneth Kong,F Aaysha Cader et al.
Nicholas Ws Chew et al.
Background: Achieving universal health coverage in the Asia-Pacific requires stronger, more equitable access to high-quality cardiovascular disease (CVD) services. Yet, despite the region's vast diversity in health system...
Centering Asian voices in global aging research: strengthening data infrastructure in East and Southeast Asia [0.03%]
在全球老龄化研究中突出亚洲声音：加强东亚和东南亚的数据基础设施
Bussarawan Teerawichitchainan
Bussarawan Teerawichitchainan
Over the past two decades, substantial investments in aging data infrastructure have transformed East and Southeast Asia from a region characterized by fragmented data coverage into one of the better empirically documented regions for aging...
Efficacy and safety of minocycline on patients with acute anterior circulation ischaemic stroke undergoing mechanical thrombectomy (MIST-A): a multicentre, prospective, randomised, open-label, blinded-endpoint, phase 2 trial [0.03%]
明胶酶抑制剂米诺环素对行机械取栓的急性前循环缺血性卒中患者的疗效和安全性：多中心、前瞻性、开放标签、盲法终点、Ⅱ期临床试验（MIST-A）
Xiao Zhang,Dong Wei,Yang Li et al.
Xiao Zhang et al.
Background: Minocycline has anti-inflammatory and neuroprotective properties. Prior clinical trials have shown potential benefits in acute ischaemic stroke (AIS), but its efficacy in patients who achieve successful reperf...
Prevalence of dual sensory impairment in Australia: a nationally representative population-based survey of Indigenous and non-Indigenous Australians [0.03%]
澳大利亚双感器质缺陷的患病率：土著居民和非土著居民全国代表性人口调查
Bamini Gopinath,Oonagh Macken,Richard Kha et al.
Bamini Gopinath et al.
Background: The prevalence of co-occurring vision and hearing impairment (Dual Sensory Impairment, DSI) is expected to increase with the global ageing population. This national survey aimed to assess the prevalence and ri...
Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort study [0.03%]
中等强度他汀类药物联合埃zeptimibe治疗与动脉粥样硬化性心血管疾病患者PCI/CABG风险：一项倾向匹配队列研究
Haonan He,Junhan Tang,Vincent Ka Chun Yan et al.
Haonan He et al.
Background: Combination therapy with moderate-intensity statins and ezetimibe has demonstrated advantages over high-intensity statin monotherapy for several cardiovascular outcomes. However, its effect on the risk of inci...